Return to Answers From the Lab

Assay identifies patients eligible for new ovarian cancer drug: Maryam Shahi, M.D.

By Samantha Rossi • April 23, 2024
Related Episodes
Get to Know the DLMP Chair: Eric Hsi, M.D.

By Sarah Jarvis • May 9, 2024
Oral fluid offers an alternative specimen for controlled substance monitoring: Paul Jannetto, Ph.D.

By Samantha Rossi • May 7, 2024
FDA Issues Final Rule to Regulate LDTs: Bill Morice, M.D., Ph.D.

By Samantha Rossi • May 2, 2024

Samantha Rossi

Samantha Rossi is a Digital Marketing Manager at Mayo Clinic Laboratories. She supports marketing strategies for product management and specialty testing. Samantha has worked at Mayo Clinic since 2019.

Related Posts
Register now to attend the 35th Leveraging the Lab Conference: Seize Tomorrow
Infectious disease test gains U.S. FDA approval
Registration now open for the 2024 Classical Hematology Conference